Abstract | AIMS: METHODOLOGY: Fourty two patients admitted for esophageal variceal bleeding confirmed at endoscopy were recruited. An initial 50 micrograms bolus of octreotide followed by a two day continuous infusion of 25 micrograms/h were evaluated for the control of bleeding. RESULTS: Twenty nine patients were endoscopic stigmata of recent bleeding and thirteen were active bleeding at emergency endoscopy. Octreotide was found to be effective regarding hemostasis at 48 hours and on day 7 after the index bleeding episode. 30-day mortality was 11.9%. Echec of octreotide was significantly associated with severity of cirrhosis (p<0.03). CONCLUSION: These results suggest that octreotide is effective in the treatment of esophageal variceal bleeding and it is a valuable adjuvant treatment in association with endoscopic management.
|
Authors | Dalenda Arfaoui, Héla Elloumi, Salem Ajmi |
Journal | La Tunisie medicale
(Tunis Med)
Vol. 82
Issue 10
Pg. 947-50
(Oct 2004)
ISSN: 0041-4131 [Print] Tunisia |
Vernacular Title | Utilisation de l'octreotide dans le traitement des hemorragies digestives aigues par rupture de varices oesophagiennes. |
PMID | 15686191
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Gastrointestinal Agents
- Octreotide
|
Topics |
- Acute Disease
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Esophageal and Gastric Varices
(complications)
- Female
- Gastrointestinal Agents
(therapeutic use)
- Gastrointestinal Hemorrhage
(drug therapy, etiology)
- Humans
- Male
- Middle Aged
- Octreotide
(therapeutic use)
- Retrospective Studies
|